CivicGraph — Accountability Brief
Australian Genomic Cancer Medicine Centre Limited
ABN 67627640733 • charity • Generated 2026-06-13
Executive Summary
- •Reported a $6.8M surplus in 2023 — financially healthy.
- •Clean political record — no political donations on file.
- •Linked to 8 evidence-backed programs in the Australian Living Map of Alternatives.
Entity Type
charity
State
NSW
SEIFA DecileSocio-Economic Indexes for Areas — decile 1 is most disadvantaged, 10 is least
—
Community Ctrl
No
Remoteness
Major Cities of Australia
LGA
Sydney
Size: Large • HPC (Health Promotion Charity — tax-deductible donations) • Purposes: Health, Social Welfare
Financial Summary
Latest Revenue
$25.3M
Latest Expenses
$18.5M
Total Assets
$64.2M
| Year | Revenue | Expenses | Assets | Surplus | Gov Rev | FTE |
|---|---|---|---|---|---|---|
| 2023 | $25.3M | $18.5M | $64.2M | $6.8M | $16.3M | 2 |
| 2022 | $16.5M | $14.7M | $20.8M | $1.8M | $11.8M | 1 |
| 2021 | $15.9M | $12.8M | $20.5M | $3.2M | $10.4M | 1 |
| 2020 | $10.9M | $9.2M | $13.2M | $1.7M | $10.0M | 2 |
| 2019 | $10.1M | $1.1M | $9.0M | $8.9M | $10.0M | 1 |
Government Funding
No government funding records found — clean record in tracked datasets.
Government Contracts
No AusTender contracts on record — clean procurement record.
Political Connections
No political donation records — clean political record.
Evidence Alignment (ALMAAustralian Living Map of Alternatives — JusticeHub's evidence database of what works)
ALMA Interventions
8
Youth Justice
0
| Intervention | Type | Evidence | Cohort |
|---|---|---|---|
| Company Studies (C3) | Therapeutic | Untested (theory/pilot stage) | Cancer patients eligible for industry-led trials |
| Genetic Cancer Risk in the Young (RisC) study – Now closed | Community-Led | Untested (theory/pilot stage) | Young individuals with inherited cancer risk |
| Cancer Screening Program (CaSP) | Community-Led | Untested (theory/pilot stage) | Patients with advanced, incurable cancer |
| Molecular Screening and Therapeutics (MoST) study | Therapeutic | Untested (theory/pilot stage) | Patients with advanced or poor prognosis cancers |
| MoST Core Studies (C1) | Therapeutic | Untested (theory/pilot stage) | Patients with advanced cancer and identified genomic biomarkers |
| Surveillance study in Multi-Organ Cancer prone syndromes (SMOC+) | Community-Led | Untested (theory/pilot stage) | Individuals at high genetic risk for multi-organ cancers |
| ASPiRATION | Therapeutic | Untested (theory/pilot stage) | Patients with advanced cancer |
| Companion Studies (C2) | Therapeutic | Untested (theory/pilot stage) | Participants in biomarker-led trials |
Geographic Context
Locality
Camperdown - Darlington
Remoteness
—
Local Ecosystem
49 orgs
Integrity Assessment
✓ABN registered
✓ACNC financials available
✓Evidence-backed programs (ALMA)
✗Government funding received
✗Government contracts held
✓No political donations
✓No donations + contracts overlap
✗Serves disadvantaged area
Data Sources & Citation
- • CivicGraph Entity Graph — 143K organisations, ABN-verified
- • ACNC Annual Information Statement — Charity financials
- • ACNC Charity Register — Charity details and purposes
- • Justice Funding Database — Federal & state funding records
- • AusTender — Federal procurement contracts
- • AEC/State ECQs — Political donation disclosures
- • Australian Living Map of Alternatives (ALMA) — JusticeHub evidence database
- • SEIFA 2021 — ABS Socio-Economic Indexes for Areas
CivicGraph Due Diligence Pack: Australian Genomic Cancer Medicine Centre Limited (ABN 67627640733). Generated 2026-06-13. Data sources: CivicGraph Entity Graph, ACNC, AusTender, AEC, ALMA.
CivicGraph — Decision Infrastructure for Government & Social Sector
This due diligence pack is auto-generated from public data sources. Verify critical claims against primary sources before inclusion in formal submissions.